share_log

DWTIがランクイン、再生医療用細胞製品の国内第2相臨床試験で投与が完了

DWTI入選,結束了再生醫療用細胞產品在國內的第二階段臨床試驗的給藥。

Fisco日本 ·  16:41

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論